Evidence map›Paper›PMID 41750269›Full record

ReviewBiomolecules2026

Hepatocyte-Derived Apoptotic Bodies as Pathological Intercellular Messengers in the Liver.

Moses New-Aaron, Lukman A Adepoju, Anup Singh Pathania, Kusum K Kharbanda, Natalia A Osna

Abstract readReview
In one paragraph

Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Moses New-AaronDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.ORCID 0000-0001-5681-1185
Lukman A AdepojuDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0009-0003-7333-7878
Anup Singh PathaniaDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0002-1517-2919
Kusum K KharbandaResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, NE 68105, USA.ORCID 0000-0001-7759-8889
Natalia A OsnaDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0001-7498-0556

Funding

Alcohol metabolism potentiates HIV-induced lung and liver multimorbidity via inter-organ crosstalkK99AA032220 · NIAAA · EMORY UNIVERSITY · PI NEW-AARON, MOSES O · 2024 to 2025
$297k
National Institute of Allergy and Infectious Diseases R01AI163042NIAAA NIH HHS K99 AA032220NIAAA NIH HHS K99AA032220NIAAA NIH HHS P50 AA030407-1531VA Office of Research and Development I01BX006064
6 · The paper itself

Abstract

Hepatocyte apoptotic bodies (ApopBDs) are extracellular vesicles formed during hepatocyte apoptosis. Although they were initially recognized as cellular waste and vesicles that clear toxic substances and viral infections in the liver, they are now known to serve as key mediators of intercellular communication that influence key metabolic and immune responses, such as inflammation, regeneration, and fibrosis. While numerous functions of ApopBDs in the liver are emerging, this review will focus on discussing their biogenesis, characterization, and roles in different liver diseases, with an emphasis on intercellular communication with liver-resident cells. The mechanisms of liver injury are convoluted by series of injurious crosstalk between hepatocyte ApopBDs and surviving resident cells. A unique feature of liver injury is a constant cycle of hepatocyte apoptosis, which has been attributed to crosstalk between surviving hepatocytes and their ApopBDs. The progression of liver injury is also affected by the activation of proinflammatory and profibrotic pathways such as TLR9/NLRP3 and JAK-STAT3. Given the expression of hepatocyte-specific molecular signatures on these ApopBDs, their application as diagnostic tools may improve the treatment of liver diseases. Although the science of hepatocyte ApopBDs is fairly recent and still emerging, in-depth understanding of this aspect of liver biology may provide a novel therapeutic option for the progression of liver damage.

Indexed as

ApoptosisExtracellular VesiclesHepatocytesLiverLiver DiseasesAnimalsCell CommunicationHumansalcoholic liver diseaseapoptosisextracellular vesicleshepatocyte apoptotic bodiesintercellular communicationnon-alcoholic steatohepatitis

Identifiers

PMID41750269
PMCPMC12938111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.